Alexion

Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?
Motley Fool
Mon, 07/19/21 - 10:52 am
Moderna Therapeutics
Alexion
S&P 500
vaccines
COVID-19
Alexion touts new PhIII data of Soliris successor as planned AstraZeneca takeover looms
Endpoints
Fri, 07/16/21 - 10:40 am
Alexion
AstraZeneca
M&A
clinical trials
Ultomiris
myasthenia gravis
AstraZeneca's planned takeover of Alexion clears last regulatory review, deal to close next week
Endpoints
Wed, 07/14/21 - 10:17 am
AstraZeneca
Alexion
M&A
AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance
PM Live
Tue, 07/6/21 - 10:59 am
AstraZeneca
Alexion
M&A
Europe
Key third-quarter readouts for big pharma
EP Vantage
Tue, 06/29/21 - 10:59 am
clinical trials
Pfizer
Roche
idanacogene elaparvovec
Alexion
AstraZeneca
Ultomiris
AbbVie
Rinvoq
Novartis
sabatolimab
Alexion, AstraZeneca executives switch roles amid $39B buyout
BioPharma Dive
Sun, 06/6/21 - 10:33 pm
AstraZeneca
Alexion
M&A
Apellis set to take on Alexion as FDA clears PNH drug Empaveli
Pharmaforum
Mon, 05/17/21 - 10:39 am
Apellis Pharmaceuticals
Alexion
Empaveli
FDA
PNH
Alexion Investors Approve Acquisition By AstraZeneca
Yahoo/SmarterAnalyst
Wed, 05/12/21 - 10:46 am
AstraZeneca
Alexion
M&A
AZ posts solid Q1 results as Alexion merger looms
Pharmforum
Fri, 04/30/21 - 10:27 am
AstraZeneca
M&A
Alexion
vaccines
earnings
Surprise: AstraZeneca's $39B Alexion buy clears a newly vigilant FTC without a hitch
Fierce Pharma
Sun, 04/18/21 - 12:04 am
AstraZeneca
Alexion
M&A
FTC
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
BridgeBio spins gold out of an Alexion castoff, scoring an FDA approval in rare metabolism disorder
Endpoints
Mon, 03/1/21 - 10:36 am
BridgeBio
fosdenopterin
Nulibry
ALXN1101
molybdenum cofactor deficiency type A
FDA
Alexion
Apellis takes the complement fight to Astrazeneca
EP Vantage
Fri, 01/22/21 - 10:30 am
Apellis
Alexion
AstraZeneca
PNH
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Newly acquired Alexion pays $100M for Rhythm's speedy review voucher
Fierce Biotech
Wed, 01/6/21 - 10:54 am
AstraZeneca
Alexion
Rhythm
priority review vouchers
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
The top 5 pharma M&A deals of 2020
Pharmaforum
Mon, 12/21/20 - 11:07 am
M&A
AstraZeneca
Alexion
Gilead Sciences
Immunomedics
Forty Seven
JNJ
Momenta
Sanofi
Principia Biopharma
[video+transcript]Is AstraZeneca Paying Too Much for Alexion?
Motley Fool
Mon, 12/21/20 - 11:00 am
M&A
AstraZeneca
Alexion
Pharmacquired: What a surprise deal does for AstraZeneca and Alexion
BioPharma Dive
Wed, 12/16/20 - 11:31 am
AstraZeneca
Alexion
M&A
Rare Diseases
AstraZeneca to buy Alexion for $39B
BioPharma Dive
Sat, 12/12/20 - 02:30 pm
AstraZeneca
Alexion
M&A
Rare Diseases

Pages